Showing results (11-20 of 398) with videos related to
Sort By:
Pageof 40
Human Psychopharmacology|December 28, 2006
Lower weight gain with the orally disintegrating olanzapine than with standard tablets in first-episode never treated psychotic patientsB Arranz, L San, R M Dueñas, et al.Psychiatry Research|November 9, 2000
Altered 5-HT(2A) binding sites and second messenger inositol trisphosphate (IP(3)) levels in hippocampus but not in frontal cortex from depressed suicide victimsP Rosel, B Arranz, L San, et al.Acta Psychiatrica Scandinavica|September 4, 2008
Clinical and serotonergic predictors of non-affective acute remitting psychosis in patients with a first-episode psychosisB Arranz, L San, N Ramírez, et al.Actas Espanolas De Psiquiatria|November 6, 2004
[Impact of medical counseling to quit smoking during the process of dehabituation in patients with mental illness]R M Dueñas Herrero, M Aleu Bover, I González Tejón, et al.Journal of Neural Transmission. General Section|January 1, 1994
[3H]paroxetine and [3H]citalopram as markers of the human brain 5-HT uptake site: a comparison studyB Arranz, J MarcussonBrain Research|August 20, 1993
Effect of aging in human cortical pre- and postsynaptic serotonin binding sitesB Arranz, A Eriksson, E Mellerup, et al.IEEE Transactions on Ultrasonics, Ferroelectrics, and Frequency Control|January 1, 1997
Determination of electromechanical coupling factors of low Q piezoelectric resonators operating in stiffened modesJ L San EmeterioNeuropsychobiology|January 1, 1992
Gamma-aminobutyric acid-B (GABAB) binding sites in postmortem suicide brainsB Arranz, R Cowburn, A Eriksson, et al.Biological Psychiatry|April 1, 1994
Brain 5-HT1A, 5-HT1D, and 5-HT2 receptors in suicide victimsB Arranz, A Eriksson, E Mellerup, et al.Biological Psychiatry|May 15, 1997
Serotonergic, noradrenergic, and dopaminergic measures in suicide brainsB Arranz, K Blennow, A Eriksson, et al.Pageof 40